SCHEMBL30962603

SCHEMBL30962603

COc1nc(Nc2cnn(C)c2)ncc1C(=O)Nc1c(C)ccc(O[Si](C)(C)C(C)(C)C)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 11/20 0.42
▸ JAK1 P23458 9/20 0.42
▸ TYK2 P29597 5/20 0.42
▸ JAK2 O60674 8/20 0.41
▸ ALK Q9UM73 3/20 0.41
▸ CDC7 O00311 2/20 0.41
▸ DAPK3 O43293 2/20 0.41
▸ ROCK2 O75116 2/20 0.41
▸ PRKD3 O94806 2/20 0.41
▸ MAP4K4 O95819 2/20 0.41
▸ PAK4 O96013 2/20 0.41
▸ PIM1 P11309 2/20 0.41
▸ PRKACA P17612 2/20 0.41
▸ CDK2 P24941 2/20 0.41
▸ SYK P43405 2/20 0.41
▸ CSNK1A1 P48729 2/20 0.41
▸ CLK2 P49760 2/20 0.41
▸ GSK3A P49840 2/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ CDK7 P50613 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962772 0.87 MAP3K7 (0.44) JAK3JAK1TYK2JAK2ALK
SCHEMBL30962743 0.85 JAK3 (0.47) JAK3JAK1TYK2JAK2ALK
SCHEMBL30962817 0.82 LCK (0.43) JAK3JAK2ALKLCKKDR
SCHEMBL30962677 0.80 NFKB1 (0.37) LCKKDRMAPK14
SCHEMBL30962908 0.76 WEE1 (0.43) JAK3JAK1JAK2LCKKDR
SCHEMBL30962750 0.76 TTK (0.40) JAK3JAK1JAK2LCKKDR
SCHEMBL30962734 0.74 JAK3 (0.48) JAK3JAK1TYK2JAK2ALK
SCHEMBL30962773 0.73 PDE4D (0.38) —
SCHEMBL30962633 0.71 NFKB1 (0.42) LCK
SCHEMBL30962899 0.71 JAK3 (0.58) JAK3JAK1TYK2JAK2ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
Send feedback